ReviewExpert review of anticancer therapy2026
An evaluation of taletrectinib for the treatment of ROS1+ non-small cell lung cancer.
Ravand Samaeekia et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it